Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:monoclonal_antibody
|
| gptkbp:administered_by |
subcutaneous injection
|
| gptkbp:chemical_formula |
C6420 H9924 N1716 O1980 S44
|
| gptkbp:developed_by |
gptkb:Abb_Vie
|
| gptkbp:effective_date |
FDA approved
|
| https://www.w3.org/2000/01/rdf-schema#label |
risankizumab
|
| gptkbp:targets |
gptkb:IL-23
|
| gptkbp:trade |
gptkb:Skyrizi
|
| gptkbp:used_for |
gptkb:Crohn's_disease
psoriasis |
| gptkbp:weight |
146 k Da
|
| gptkbp:bfsParent |
gptkb:Skyrizi
|
| gptkbp:bfsLayer |
5
|